J. Van Gelder

648 citations
15 papers · 444 indexed · h-index 13

J. Van Gelder

15 papers receiving 431 citations

Peers

J. Van Gelder
Comparison fields: 5 of 77
  • Pharmaceutical Science 133
  • Virology 58
  • Infectious Diseases 115
  • Pharmacology 48
  • Oncology 144
Replace Doo‐Man Oh with:
Doo‐Man Oh United States
S. Deferme Belgium
Jignesh Patel United States
Ravinder Earla United States
Suresh Katragadda United States
Gary D. Bowers United States
Chantal Masungi Belgium
Tomoki Imaoka Japan
Mitesh Patel United States
Constantin Efthymiopoulos United Kingdom
J. Van Gelder relative to Doo‐Man Oh United States Doo‐Man Oh's profile →
Citations per field
00.5×2.8×
Doo‐Man Oh · 1×
Citations per year

Countries citing papers authored by J. Van Gelder

Since Specialization
Citations

This map shows the geographic impact of J. Van Gelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Van Gelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Van Gelder more than expected).

Fields of papers citing papers by J. Van Gelder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Van Gelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Van Gelder. The network helps show where J. Van Gelder may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. Van Gelder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Van Gelder Line = papers co-authored together J. Van Gelder links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 201223
2 200838
3 200647
4 200281
5 200221
6 200235
7 200052
8 200030
9
Oral absorption characteristics of the antiviral agent UC-781
20001
10 200036
11
Increased oral absorption of the antiviral ester prodrug Tenofovir disoproxil in rat ileum
20003
12 199925
13 199918
14 199817
15 199517

About J. Van Gelder

J. Van Gelder is a scholar working on Infectious Diseases, Physiology and Virology, having authored 15 papers that have together received 444 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Biochemical and Molecular Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Hepatitis C virus research (3 papers), Adenosine and Purinergic Signaling (2 papers), HIV Research and Treatment (2 papers), Protein purification and stability (2 papers) and Protein Interaction Studies and Fluorescence Analysis (1 paper). The work is most often cited by research in Pharmaceutical Science (133 citations), Virology (58 citations) and Infectious Diseases (115 citations). J. Van Gelder has collaborated with scholars based in Belgium, Australia and Netherlands. Frequent co-authors include Patrick Augustijns, Erik De Clercq, Renaat Kinget, Lieve Naesens, S. Deferme, Guy Van den Mooter, Guy Van den Mooter, Pieter Annaert, Xuan Ding and John P. Rose. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026